Prenatal Genetics

We offer access to the latest and most advanced prenatal genetic screening, imaging and other diagnostic testing to help identify certain genetic disorders causing rare diseases in developing babies and newborns as early as possible so that they may benefit from prevention strategies, genetic counseling and early therapy and intervention.

Our services include early noninvasive prenatal screening tests, including carrier screening before and during pregnancy, quadruple and penta screening, cell-free DNA analysis, early risk assessment and massively parallel sequencing for noninvasive prenatal DNA testing (NIPT), as well as 3D and 4D obstetric ultrasound imaging.

For prenatal diagnosis using minimally invasive techniques, we work as a unified team with our Department of Obstetrics & Gynecology & Women’s Health. We specialize in performing chorionic villus sampling, amniocentesis and cordocentesis to collect fetal cells, as well as sophisticated blastocyst biopsy for preimplantation embryo diagnostics. Our chromosomal analysis technologies include advanced cytogenetic testing, such as karyotyping, chromosomal microarray analysis and fluorescence in situ hybridization (FISH). 

Identifying a genetic condition and/or a fetal anomaly during the prenatal period can allow parents and clinicians to prepare and explore further diagnostic, reproductive and treatment options. It can enable early intervention, such as fetal drug or enzyme replacement therapy, in utero gene therapy and fetal surgery for certain conditions. We’re among the elite 1% of hospitals in the U.S. performing complex, in utero fetal surgeries for high-risk, rare and life-threatening conditions to help improve long-term health and postnatal outcomes.